0001209191-22-062657.txt : 20221223 0001209191-22-062657.hdr.sgml : 20221223 20221223171302 ACCESSION NUMBER: 0001209191-22-062657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221201 FILED AS OF DATE: 20221223 DATE AS OF CHANGE: 20221223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Caroline CENTRAL INDEX KEY: 0001684087 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 221486079 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE, SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-01 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001684087 Young Caroline 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2022-12-01 4 P 0 20 2.33 A 19228 D Common Stock 2022-12-02 4 P 0 20 2.31 A 19248 D Common Stock 2022-12-05 4 P 0 20 2.19 A 19268 D Common Stock 2022-12-06 4 P 0 20 2.19 A 19288 D Common Stock 2022-12-07 4 P 0 20 2.18 A 19308 D Common Stock 2022-12-08 4 P 0 20 2.19 A 19328 D Common Stock 2022-12-09 4 P 0 20 2.15 A 19348 D Common Stock 2022-12-12 4 P 0 20 2.14 A 19368 D Common Stock 2022-12-13 4 P 0 20 2.18 A 19388 D Common Stock 2022-12-14 4 P 0 20 2.21 A 19408 D Common Stock 2022-12-15 4 P 0 20 2.24 A 19428 D Common Stock 2022-12-16 4 P 0 20 2.22 A 19448 D Common Stock 2022-12-19 4 P 0 30 2.21 A 19478 D Common Stock 2022-12-20 4 P 0 109 2.31 A 19587 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022. Caroline Young by /s/ John Hamm as attorney-in-fact 2022-12-23